Details for Patent: 8,785,426

Which drugs does patent 8,785,426 protect, and when does it expire?

Patent 8,785,426 protects VOGELXO and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 8,785,426

Title:	Testosterone gel compositions and related methods
Abstract:	Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.
Inventor(s):	Harish K. Pimplaskar
Assignee:	Upsher Smith Laboratories LLC
Application Number:	US14/177,765
Patent Claim Types: see list of patent claims	Use; Composition; Delivery;

Drugs Protected by US Patent 8,785,426

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Upsher Smith Labs	VOGELXO	testosterone	GEL, METERED;TRANSDERMAL	204399-003	Jun 4, 2014	BX	RX	No	No	8,785,426		Y			METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
Upsher Smith Labs	VOGELXO	testosterone	GEL;TRANSDERMAL	204399-002	Jun 4, 2014	AB2	RX	No	No	8,785,426		Y			METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE

International Family Members for US Patent 8,785,426

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014362275
Canada	2857286
European Patent Office	3079703
Hong Kong	1223852
Singapore	11201604788U